GlassScriptPhysician profile
Jerome M Itzkoff
NPI 1972558815
$1,375.81
in general payments reported to CMS, 2019-2025
24 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $73.72 · 2021: $179 · 2022: $144 · 2023: $289 · 2024: $200 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $314.45 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $135.29 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.87 | 2020-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $94.69 | 2021-2025 | Verquvo |
| Heartflow, INC. | $94.40 | 2022-2023 | Ffrct |
| Janssen Pharmaceuticals, INC | $90.95 | 2019-2024 | Xarelto |
| Pfizer INC. | $82.11 | 2019-2023 | |
| Amgen INC. | $56.96 | 2019 | |
| Alnylam Pharmaceuticals INC. | $48.03 | 2024-2025 | Onpattro |
| Kestra Medical Technology Services, INC. | $40.72 | 2023 | Assure Wcd |
| Novo Nordisk INC | $38.04 | 2023 | Ozempic, Rybelsus |
| Abiomed | $36.87 | 2024-2025 | Impella |
| Vifor Pharma, INC. | $36.37 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $28.37 | 2023-2025 | Camzyos |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $24.81 | 2023 | |
| Medicomp INC | $20.81 | 2025 | Telepatch Cardiac Monitor |
| Inspire Medical Systems, INC. | $18.55 | 2025 | Inspire |
| Boston Scientific Corporation | $18.38 | 2021 | |
| Cook Medical LLC | $16.23 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.08 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $14.01 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $12.93 | 2022 | |
| Daiichi Sankyo INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Itzkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.